UA94917C2 - Композиции для местного применения - Google Patents

Композиции для местного применения

Info

Publication number
UA94917C2
UA94917C2 UAA200804715A UAA200804715A UA94917C2 UA 94917 C2 UA94917 C2 UA 94917C2 UA A200804715 A UAA200804715 A UA A200804715A UA A200804715 A UAA200804715 A UA A200804715A UA 94917 C2 UA94917 C2 UA 94917C2
Authority
UA
Ukraine
Prior art keywords
pharmaceutical
polymers
film
formulation
forming agent
Prior art date
Application number
UAA200804715A
Other languages
English (en)
Ukrainian (uk)
Inventor
Марк Барри Браун
Стюарт Аллен Джонс
Original Assignee
Медфарм Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Медфарм Лимитед filed Critical Медфарм Лимитед
Publication of UA94917C2 publication Critical patent/UA94917C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/124Aerosols; Foams characterised by the propellant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение касается фармацевтической композиции, которая способна образовывать пленку при местном нанесении, где указанная композиция содержит состав из фармацевтического средства, растворителя для него, образующего пленку средства и пропелента, где композиция является монофазной, а фармацевтическое средство присутствующее по сути в насыщающем количестве при условиях использования, при этом фармацевтическое средство присутствует при величине насыщения по меньшей мере 80 %, где образующее пленку средство выбрано из группы, которая состоит из поливинилпиролидона, поливинилового спирта, акриловых полимеров, акриловых сополимеров, метакрылатных полимеров, метакрылатных сополимеров, поливинилацетата, полимеров на основе целлюлозы и сополимеров на основе целлюлозы, в количестве от 0,1 до 40 % мас./мас. включительно.
UAA200804715A 2005-09-14 2006-09-14 Композиции для местного применения UA94917C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0518769.5A GB0518769D0 (en) 2005-09-14 2005-09-14 Topical formulations

Publications (1)

Publication Number Publication Date
UA94917C2 true UA94917C2 (ru) 2011-06-25

Family

ID=35221491

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200804715A UA94917C2 (ru) 2005-09-14 2006-09-14 Композиции для местного применения

Country Status (21)

Country Link
US (1) US8349297B2 (ru)
EP (1) EP1931310B1 (ru)
JP (2) JP5677720B2 (ru)
KR (1) KR101326207B1 (ru)
CN (1) CN101304730B (ru)
AU (1) AU2006290487B2 (ru)
BR (1) BRPI0616061A2 (ru)
CA (1) CA2622624C (ru)
DK (1) DK1931310T3 (ru)
ES (1) ES2391782T3 (ru)
GB (1) GB0518769D0 (ru)
IL (1) IL190174A (ru)
NO (1) NO339113B1 (ru)
NZ (1) NZ567022A (ru)
PL (1) PL1931310T3 (ru)
PT (1) PT1931310E (ru)
RU (1) RU2428970C2 (ru)
SI (1) SI1931310T1 (ru)
UA (1) UA94917C2 (ru)
WO (1) WO2007031753A2 (ru)
ZA (1) ZA200803150B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9283177B2 (en) * 2007-01-16 2016-03-15 Juventio, Llc Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
CA2675797A1 (en) 2007-01-16 2008-07-24 Dermworx, Incorporated Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic
CA2730787A1 (en) * 2008-07-16 2010-01-21 David M. Cohen Topical drug delivery system
WO2010019953A1 (en) 2008-08-15 2010-02-18 Arcion Therapeutics, Inc. High concentration local anesthetic formulations for treating non-neuropathic pain
US20100202978A1 (en) * 2009-02-12 2010-08-12 Gurge Ronald M Foamable benzoyl peroxide compositions for topical administration
MX2012003588A (es) * 2009-09-25 2012-07-25 Pharmasol Corp Recubrimientos superficiales para la piel.
WO2011061155A1 (en) 2009-11-17 2011-05-26 Bayer Consumer Care Ag Antifungal formulations and their use
KR20150036825A (ko) * 2010-04-13 2015-04-07 나지브 바불 1-메틸-2''-6''-피페콜옥실리디드의 피부 약제학적 조성물 및 사용 방법
EP2409702A1 (en) 2010-07-21 2012-01-25 Bayer Innovation GmbH Combination of siloxane and active ingredient for treating dental disorder of hard tissues
MX2014015657A (es) 2012-07-06 2015-03-20 Leo Pharma As Composicion topica que comprende un polimero formador de pelicula para liberar un ingrediente activo a la piel.
RU2507600C1 (ru) * 2012-07-20 2014-02-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ и устройство для моделирования инфицированной раны слизистой оболочки полости рта в эксперименте
CN102772801B (zh) * 2012-08-10 2014-10-15 江苏长泰药业有限公司 一种用于治疗擦伤的伤口喷雾剂及其制备方法
FR3010635B1 (fr) * 2013-09-13 2017-01-20 Pf Medicament Compositions pharmaceutiques a base d'agent filmogene pour le traitement de l'hyposialie
DE102015209752A1 (de) 2015-05-28 2016-12-01 Beiersdorf Ag Sprühfähige hochviskose kosmetische Zubereitung
WO2017091739A1 (en) * 2015-11-23 2017-06-01 Grace Therapeutics Llc Topical film-forming spray
FR3064488B1 (fr) * 2017-03-31 2021-01-01 Urgo Rech Innovation Et Developpement Composition contenant un derive de cellulose, un plastifiant, un solvant volatil et un actif, ses utilisations comme pansement
AU2018378072B2 (en) 2017-12-04 2024-05-23 Kenvue Brands Llc Topical emulsion composition containing nonsteroidal anti-inflammatory drug
EP3927320A2 (en) 2019-02-19 2021-12-29 Bluepharma Indústria Farmacêutica, S.A. Mucoadhesive compositions and uses thereof
WO2023250369A2 (en) * 2022-06-21 2023-12-28 Taro Pharmaceutical Industries Ltd. Topical naftifine compositions
JP2025536556A (ja) 2022-10-25 2025-11-07 ヴェラダーミクス インコーポレイテッド 放出調節ミノキシジル用組成物および使用方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4534958A (en) * 1983-07-13 1985-08-13 Basf Wyandotte Corporation Aerosol gel
ZA859160B (en) 1984-08-29 1986-07-30 Denis Glynn Catton Dip compositions
DE3612305A1 (de) 1986-04-11 1987-10-22 Roehm Pharma Gmbh Fluessige arzneiform zur therapie der psoriasis auf basis filmbildender polymere
US4863721A (en) * 1987-05-22 1989-09-05 The Procter & Gamble Company Reduced stinging antiperspirant compositions
ATE72129T1 (de) 1987-05-27 1992-02-15 Burghart Kurt Transdermal therapeutisch wirkende pharmazeutische zubereitung sowie vorrichtung zum aufbringen der zubereitung.
JPS6450816A (en) * 1987-08-21 1989-02-27 Kanebo Ltd Isosorbide nitrate agent for transcutaneous use
US4752466A (en) 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
JPH01230514A (ja) * 1987-11-25 1989-09-14 Osaka Aerosol Ind Corp エアゾール型外用貼付剤
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
MX9203481A (es) 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
US6123924A (en) 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
PT731688E (pt) 1993-12-02 2003-07-31 Abbott Lab Formulacoes de farmacos em aerossol para utilizacao com propulsores sem cfc
GB9404248D0 (en) * 1994-03-05 1994-04-20 Boots Co Plc Pharmaceutical formulations
JP3881400B2 (ja) 1995-02-22 2007-02-14 久光製薬株式会社 エアゾール組成物及びエアゾール型外用製剤
FR2740038B1 (fr) 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
JPH111433A (ja) * 1997-06-13 1999-01-06 Shionogi & Co Ltd トルナフテ−ト含有液剤
FR2787712B1 (fr) * 1998-12-24 2002-08-30 Sanofi Sa Composition cosmetique pulverisable et matrice utilisable dans cette composition pour une administration dermique
DK1150661T3 (da) 1999-02-05 2004-03-01 Cipla Ltd Topiske sprays der omfatter et filmdannende præparat
US6962691B1 (en) * 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
US7083781B2 (en) 1999-08-19 2006-08-01 Lavipharm S.A. Film forming polymers, methods of use, and devices and applications thereof
US6432415B1 (en) * 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
US7820615B2 (en) * 2000-05-11 2010-10-26 Rhe Procter & Gamble Company Method of providing delayed release of a volatile solvent from hydro-alcoholic cosmetic compositions
FR2808685B1 (fr) 2000-05-12 2004-10-08 Sanofi Synthelabo Compositions pharmaceutiques pour administration transdermique d'agents anti-inflammatoires
JP4450545B2 (ja) * 2001-07-05 2010-04-14 ロート製薬株式会社 エアゾール製剤
GB0218996D0 (en) * 2002-08-14 2002-09-25 Novartis Ag Organic compounds
ME00420B (me) * 2003-03-20 2011-12-20 Boehringer Ingelheim Pharmaceuticals Inc Formulacija, za inhalator u kojem se odmjerava doza, u kojoj se kao propelenti koriste hidro-fluoro-alkani
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
BRPI0415725A (pt) * 2003-10-23 2006-12-19 Cipla Ltd formulação aspergìvel transdérmica, método para administrar um agente farmaceuticamente ativo e método para formar uma pelìcula farmaceuticamente ativa

Also Published As

Publication number Publication date
KR20080045272A (ko) 2008-05-22
IL190174A0 (en) 2008-08-07
AU2006290487A1 (en) 2007-03-22
JP2013067651A (ja) 2013-04-18
NO20081790L (no) 2008-06-11
GB0518769D0 (en) 2005-10-19
CA2622624A1 (en) 2007-03-22
PT1931310E (pt) 2012-09-12
DK1931310T3 (da) 2012-09-17
BRPI0616061A2 (pt) 2011-06-07
CN101304730A (zh) 2008-11-12
JP2009507911A (ja) 2009-02-26
JP5677720B2 (ja) 2015-02-25
EP1931310A2 (en) 2008-06-18
RU2008114352A (ru) 2009-10-20
PL1931310T3 (pl) 2012-11-30
US8349297B2 (en) 2013-01-08
EP1931310B1 (en) 2012-06-06
CN101304730B (zh) 2011-01-19
KR101326207B1 (ko) 2013-11-11
WO2007031753A3 (en) 2007-06-07
RU2428970C2 (ru) 2011-09-20
ZA200803150B (en) 2009-06-24
CA2622624C (en) 2013-10-29
AU2006290487B2 (en) 2012-06-28
ES2391782T3 (es) 2012-11-29
US20090191271A1 (en) 2009-07-30
WO2007031753A2 (en) 2007-03-22
NO339113B1 (no) 2016-11-14
IL190174A (en) 2015-06-30
NZ567022A (en) 2011-06-30
SI1931310T1 (sl) 2012-10-30

Similar Documents

Publication Publication Date Title
CA2435729A1 (en) New film coating
WO2007052125A3 (en) Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent
CA2312710A1 (en) Sustained release formulation containing three different types of polymers and tablet formed therefrom
WO2002051385A8 (en) Solid dispersions of nitrate active principles
CA2411277A1 (en) Neurotoxin implant
UA95993C2 (ru) Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
CA2214100A1 (en) Sustained release formulation containing three different types of polymers
KR950005301A (ko) 방출 개시 제어 및 방출 속도 제어형 제제
AU2963400A (en) Improved controlled release compositions and method
WO2001085143A3 (fr) Compositions pharmaceutiques pour administration transdermique d' agents anti-inflammatoires
EP1177788A3 (en) Pharmaceutical composition of fluoxetin in coated dispersible tablets and process for its manufacture
WO2007031753A3 (en) Topical film-forming monophasic formulations
WO2002094215A3 (en) Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vimyl acetate as surface stabilizers
WO2002030402A3 (en) Film for active ingredients dermal and transdermal administration
EP1340797A3 (en) Aqueous dispersion type pressure-sensitive adhesive composition and pressure-sensitive adhesive product
RU2009111866A (ru) Композиция для ухода за зубным протезом
MY109271A (en) Ozone-friendly correction fluid containing a butyl methacrylate copolymer as a film forming binder
CA2609750A1 (en) Shave composition containing three types of lubricants
TNSN08094A1 (en) Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis
WO2002060417A8 (de) Lagerstabiles haft- und bindemittel für pharmazeutische anwendungen
AU2001292754A1 (en) Protectant film for skin
SE0202353D0 (sv) New film coating
NO20055601L (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
CA2420712A1 (en) Fast release cefuroxime axetil compositions